0 Комментарии
0 Поделились
502 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Статьи пользователей
-
Offers
-
Jobs
-
Courses
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Are Personalized Cancer Vaccines Transforming the Future of Oncology?Latest Insights on Executive Summary Personalized Cancer Vaccines Market Share and Size CAGR Value The market insights gained through this keyword market research analysis report facilitate a more defined understanding of the market landscape, issues that may interrupt in the future, and ways to position a definite brand excellently. With the scrupulous competitor analysis covered in...0 Комментарии 0 Поделились 18 Просмотры 0 предпросмотр
-
Clinical Next-Generation Sequencing Testing Market Advances Precision Medicine ApplicationsExecutive Summary Clinical Next-Generation Sequencing (NSG) Testing Market Size and Share Forecast The global clinical next-generation sequencing (NSG) testing market size was valued at USD 8.92 billion in 2025 and is expected to reach USD 61.32 billion by 2033, at a CAGR of 27.25% during the forecast period By considering a definite base year...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Colorectal Cancer Treatment Market Advances with Targeted Therapies"Executive Summary Colorectal Cancer Treatment Market Size and Share: Global Industry Snapshot Data Bridge Market Research analyses a growth rate in the colorectal cancer treatment market in the forecast period 2023-2030. The expected CAGR of colorectal cancer treatment market is tend to be around 4% in the mentioned forecast period. Research and analysis about the key...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Colorectal Cancer Treatment Market Progresses with Advances in Targeted and ImmunotherapiesRegional Overview of Executive Summary Colorectal Cancer Treatment Market by Size and Share The expected CAGR of colorectal cancer treatment market is tend to be around 4% in the mentioned forecast period. The market is valued at USD 19 billion in 2022, and it would grow upto USD 26 billion by 2030. Colorectal Cancer Treatment Market analysis gives a clear idea on various segments...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Could the Tumor Markers Testing Market Revolutionize Early Cancer Detection?Executive Summary Tumor Markers Testing Market Size and Share Analysis Report CAGR Value Data Bridge Market Research analyses the tumor markers testing market growth rate in 2023-2030. The expected CAGR of the tumor markers testing market is around 7.70% in the mentioned forecast period. The market was valued at USD 16.7 billion in 2022 and would grow to USD 30.23 billion by 2030...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Global Cancer Diagnostics Market to Reach USD 178.26 Billion by 2033, Driven by Rising Screening DemandMarket Overview The global cancer diagnostics market size was valued at USD 106.32 billion in 2024 and is projected to reach from USD 112.60 billion in 2025 to USD 178.26 billion by 2033, growing at a CAGR of 5.91% during the forecast period (2025-2033). The global Cancer Diagnostics market continues to evolve rapidly, driven by shifting consumer trends,...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
How Cancer Treatment Demand Is Expanding the Asia-Pacific Taxane MarketExecutive Summary Asia-Pacific Taxane Market Size and Share: Global Industry Snapshot CAGR Value Asia-Pacific taxane market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 8.7% in the forecast period of 2022 to 2029. The research and analysis carried out in this Asia-Pacific Taxane...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
How Is CTC-Based Liquid Biopsy Advancing Cancer Diagnostics in Europe?"Executive Summary Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Share Forecast Data Bridge Market Research analyses that the market is growing with a CAGR of 24.3% in the forecast period of 2022 to 2029 and is expected to reach USD 1,891.60 million by 2029 from USD 351.05 million in 2021. By considering a definite base year and historic year, calculations in the...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
How Is CTC-Based Liquid Biopsy Advancing Cancer Diagnostics in Europe?"Executive Summary Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Share Forecast Data Bridge Market Research analyses that the market is growing with a CAGR of 24.3% in the forecast period of 2022 to 2029 and is expected to reach USD 1,891.60 million by 2029 from USD 351.05 million in 2021. By considering a definite base year and historic year, calculations...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
How the Prostate Cancer Diagnostics Market Is Advancing with AI and Biomarker-Based Screening?Executive Summary Prostate Cancer Diagnostics Market: Growth Trends and Share Breakdown CAGR Value The global prostate cancer diagnostics market size was valued at USD 4.63 billion in 2024 and is expected to reach USD 10.31 billion by 2032, at a CAGR of 10.50% during the forecast period Prostate Cancer Diagnostics Market research report is a verified source of data and information that...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Is the Global Clinical NGS Testing Market Transforming Precision Medicine?Executive Summary Clinical Next-Generation Sequencing (NSG) Testing Market: Growth Trends and Share Breakdown CAGR Value The global clinical next-generation sequencing (NSG) testing market size was valued at USD 8.92 billion in 2025 and is expected to reach USD 61.32 billion by 2033, at a CAGR of 27.25% during the forecast period This Clinical...0 Комментарии 0 Поделились 99 Просмотры 0 предпросмотр
-
Is the Global EPO Drugs Market Expanding With Rising Chronic Kidney Disease and Anemia Cases?Executive Summary Erythropoietin (EPO) Drugs Market Size and Share Forecast The global erythropoietin (EPO) drugs market size was valued at USD 9.12 billion in 2024 and is expected to reach USD 22.60 billion by 2032, at a CAGR of 12.00% during the forecast period The Erythropoietin (EPO) Drugs report also makes available CAGR value fluctuation...0 Комментарии 0 Поделились 611 Просмотры 0 предпросмотр
Расширенные страницы
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek